Crossmark

Newcastle disease virus enhances the antitumor efficacy of Doxorubicin in a cervical cancer mouse model

Published Online: 2024-10-10

Authors

Rasekhi Kazeruni, Aezam

Babaei, Nahid

Esmaeili Gouvarchin Ghaleh, Hadi

Doosti, Abbas

Farzanehpour, Mahdieh
License Information

Text and Data Mining valid from 2024-10-10

Version of Record valid from 2024-10-10
More Information

Article History

Received: 10 May 2024

Accepted: 30 September 2024

First Online: 10 October 2024

Declarations

:

: The authors declare no competing interests.

Document is current